Novoroo Bioscience
Australia
About Novoroo Bioscience
Novoroo Bioscience is dedicated to advancing remyelination therapies in multiple sclerosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $250.0K
- Last round: Grant (Jan 2026)
- Website: novoroo.com
Industries & Categories
Biotechnology, Life Science, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/novoroo-bioscience-8114 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.